15-Deoxy-Δ12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: Possible roles of iron and ROS

Carcinogenesis

Volumn 30, Issue 4, 2009, Pages 645-654

  Kim, Do Hee ^a   Kim, Jung Hyun ^a   Kim, Eun Hee ^a   Na, Hye Kyung ^a   Cha, Young Nam ^b   Chung, Jin Ho ^c   Surh, Young Joon ^a  

^a Seoul National University   (South Korea)

^b Inha University School of Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; 15 DEOXY DELTA12,14 PROSTAGLANDIN J2; ACETYLCYSTEINE; DEFEROXAMINE; FERRIC ION; HEME OXYGENASE 1; HEMIN; INTERSTITIAL COLLAGENASE; IRON; PROTOPORPHYRIN COBALT; PROTOPORPHYRIN ZINC; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; 1,10-PHENANTHROLINE; 15 DEOXY DELTA(12,14) PROSTAGLANDIN J2; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J2; DRUG DERIVATIVE; IMMUNOLOGIC FACTOR; IRON CHELATING AGENT; LUCIFERASE; MESSENGER RNA; NFE2L2 PROTEIN, HUMAN; PHENANTHROLINE DERIVATIVE; PROSTAGLANDIN D2; PROTOPORPHYRIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IRON CHELATION; METASTASIS; METASTASIS POTENTIAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; BREAST TUMOR; CELL MOTION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WOUND HEALING;

BREAST NEOPLASMS; CELL MOVEMENT; HEME OXYGENASE-1; HUMANS; IMMUNOLOGIC FACTORS; IRON; IRON CHELATING AGENTS; LUCIFERASES; MATRIX METALLOPROTEINASE 1; NF-E2-RELATED FACTOR 2; PHENANTHROLINES; PROSTAGLANDIN D2; PROTOPORPHYRINS; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; UP-REGULATION; WOUND HEALING;

EID: 64349099334     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp012     Document Type: Article

References (49)

1. American Cancer Society. Cancer Facts and Figures 2008. Atlanta, GA: American Cancer Society; 2008.
2. Costa,C. et al. (2002) Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J. Clin. Pathol., 55, 429-434.
3. Ranger,G.S. et al. (2004) Elevated cyclooxygenase-2 expression correlates with distant metastases in breast cancer. Anticancer Res. 24, 2349-2351.
4. Singh,B. et al. (2005) COX-2 overexpression increases motility and invasion of breast cancer cells. Int. J. Oncol., 26, 1393-1399.
5. Ristimaki,A. et al. (2002) Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res., 62 632-635.
6. Nassar,A. et al. (2007) COX-2 expression in invasive breast cancer: Correlation with prognostic parameters and outcome. Appl. Immunohistochem. Mol. Morphol., 15, 255-259.
7. Singh,B. et al. (2007) COX-2 involvement in breast cancer metastasis to bone. Oncogene, 26, 3789-3796.
8. Na,H.K. et al. (2003) Peroxisome proliferator-activated receptor gamma (PPARc) ligands as bifunctional regulators of cell proliferation. Biochem. Pharmacol., 66, 1381-1391.
9. 2, an endogenous ligand of peroxisome proliferator-activated receptor gamma, in tumor angiogenesis. Biochem. Pharmacol., 76, 1544-1553.
10. 2 in a model of skin carcinogenesis. Carcinogenesis, 27, 328-336.
11. 2 and the precursors in leukemia cell line THP-1. J. Pharmacol. Sci., 94, 261-270.
12. 2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells. Cancer Res., 59, 2739-2746.
13. 2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: A potential role of ROS. Carcinogenesis, 29, 688-695.
14. 2 via heme oxygenase-1 and ERK1/2 signaling in MCF-7 cells. Ann. N. Y. Acad. Sci., 1090, 375-384.
15. 2 in human mesangial cells. Kidney Int., 65, 798-810.
16. Kim,E.H. et al. (2004) Effects of cyclopentenone prostaglandins on the expression of heme oxygenase-1 in MCF-7 cells. Ann. N. Y. Acad. Sci., 1030, 493-500.
17. 2 on VEGF synthesis depends on the induction of heme oxygenase-1. Antioxid. Redox Signal., 4, 577-585.
18. Otterbein,L.E. et al. (2000) Heme oxygenase: Colors of defense against cellular stress. Am. J. Physiol. Lung Cell. Mol. Physiol., 279, L1029-L1037.
19. Dulak,J. et al. (2004) Complex role of heme oxygenase-1 in angiogenesis. Antioxid. Redox Signal., 6, 858-866.
20. Was,H. et al. (2006) Overexpression of heme oxygenase-1 in murine melanoma: Increased proliferation and viability of tumor cells, decreased survival of mice. Am. J. Pathol., 169, 2181-2198.
21. Fang,J. et al. (2003) In vivo antitumor activity of pegylated zinc protoporphyrin: Targeted inhibition of heme oxygenase in solid tumor. Cancer Res., 63, 3567-3574.
22. Hood,J.D. et al. (2002) Role of integrins in cell invasion and migration. Nat. Rev. Cancer, 2, 91-100.
23. Rundhaug,J.E. (2005) Matrix metalloproteinases and angiogenesis. J. Cell. Mol. Med., 9, 267-285.
24. Weigelt,B. et al. (2005) Breast cancer metastasis: Markers and models. Nat. Rev. Cancer, 5, 591-602.
25. Balduyck,M. et al. (2000) Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro. Clin. Exp. Metastasis, 18, 171-178.
26. Eck,S.M. et al. (2008) Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model. Breast Cancer Res. Treat., (Epub ahead of print).
27. 2-terminal kinase signaling axis regulates diallyl trisulfide-induced generation of reactive oxygen species and cell cycle arrest in human prostate cancer cells. Cancer Res., 66, 5379-5386.
28. Miralem,T. et al. (2005) Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells. J. Biol. Chem., 280 17084-17092.
29. Chen,G.G. et al. (2004) Heme oxygenase-1 protects against apoptosis induced by tumor necrosis factor-alpha and cycloheximide in papillary thyroid carcinoma cells. J. Cell. Biochem., 92, 1246-1256.
30. Liu,Z.M. et al. (2004) Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells. Oncogene, 23, 503-513.
31. Brenneisen,P. et al. (1998) Central role of ferrous/ferric iron in the ultraviolet B irradiation-mediated signaling pathway leading to increased interstitial collagenase (matrix-degrading metalloprotease (MMP)-1) and stromelysin-1 (MMP-3) mRNA levels in cultured human dermal fibroblasts. J. Biol. Chem., 273, 5279-5287.
32. Ryter,S.W. et al. (2006) Heme oxygenase-1/carbon monoxide: From basic science to therapeutic applications. Physiol. Rev., 86 583-650.
33. Sivula,A. et al. (2005) Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer. Breast Cancer Res. Treat., 89, 215-220.
34. Ala-aho,R. et al. (2005) Collagenases in cancer. Biochimie, 87, 273-286.
35. Boire,A. et al. (2005) PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120, 303-313.
36. Jozkowicz,A. et al. (2003) Heme oxygenase and angiogenesis activity of endothelial cells: Stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX. Antioxid. Redox Signal., 5 155-162.
37. Lin,C.W. et al. (2008) Heme oxygenase-1 inhibits breast cancer invasion via suppressing the expression of matrix metalloproteinase-9. Mol. Cancer Ther., 7, 1195-1206.
38. Liu,H. et al. (2003) PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro. Breast Cancer Res. Treat., 79, 63-74.
39. Deramaudt,B.M. et al. (1998) Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J. Cell Biochem., 68, 121-127.
40. Sunamura,M. et al. (2003) Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis, 6, 152-4.
41. Wayman,N.S. et al. (2002) Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J., 16, 1027-1040.
42. Dulak,J. et al. (2002) Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid. Redox Signal., 4, 229-240.
43. Ferrara,N. et al. (2003) The biology of VEGF and its receptors. Nat. Med., 9, 669-676.
44. Rajagopalan,S. et al. (1996) Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J. Clin. Invest., 98, 2572-2579.
45. Le,N.T. et al. (2002) The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim. Biophys. Acta, 1603, 31-46.
46. Desmard,M. et al. (2005) Carbon monoxide reduces the expression and activity of matrix metalloproteinases 1 and 2 in alveolar epithelial cells. Cell. Mol. Biol. (Noisy-le-grand), 51, 403-408.
47. Clevers,H. (2004) At the crossroads of inflammation and cancer. Cell 118, 671-674.
48. 2 in mouse skin. Carcinogenesis, 28, 2063-2068.
49. 2 levels as a predictor of periodontal attachment loss. J. Periodontal Res., 21, 101-112.